Summary
Fifty five patients with small cell lung cancer were treated with a VP16-213 combination chemotherapy regimen in two consectutive series. The first series included 24 patients; 10 with limited and 14 with extensive disease were treated with VP16-213, 120 mg/m2 p.o. daily for 5 consecutive days, Cyclophosphamide 600 mg/m2 i.v. and Cisplatin 80 mg/m2 i.v. with hydratation and manitol induced diuresis. The cycle was repeated every 3 weeks. The second series included 31 similar patients, 16 limited, and 15 extensive disease, treated with VP16-213 at the same dose and Cyclophosphamide at 1,200 mg/m2 i.v. also repeated every 3 weeks; after three cycles the patients were treated with radiotherapy to the primary tumor and regional lymph nodes with 4,000 rads in a split course of three weeks interval, followed by the same combination chemotherapy. Response rate was 75% for the first series with 6 of 24 (25%) of complete responses in four limited and two extensive disease and a median survival time of 24 weeks. In the second series of patients there were 26 of 31 (83.8%) responses with 10 of 31 (32%) complete responses in nine limited and one extensive disease and a median survival time of 33 weeks for responders. Duration of response for complete responders was 36.8 weeks for the first series and 51 weeks for the second. Toxicity was mild and includes nausea and vomiting, myelosupression, alopecia in both series, with one toxic death in the second series.
Both regimens are active with a low complete response rate, which was increased in the second series by the addition of radiotherapy, which did not increase overall survival.
Similar content being viewed by others
References
Bleehen NM (1979) Medical research council lung cancer working party: Radiotherapy alone or with chemotherapy in the treatment of small cell carcinoma of the lung. Br J Cancer 40:1–10
Broder LE, Cohen MH, Selawry OS (1977) Treatment of small cell bronchogenic carcinoma. Cancer Treat Rev 4:219–260
Bunn PA Jr, Cohen MH, Ihde DC (1977) Commentary: Advances in small cell bronchogenic carcinoma. Cancer Treat Rep 61:333–342
Cameron SJ, Grant INB, Crompton GK (1974) Cyclophosphamide in disseminated bronchial carcinoma. Scott Med J 19:81–86
Cavalli F, Brunner K, Jungi F (1977) A comparison of three treatments schedules of VP16-213 (NSC-141540) in the treatment of anaplastic carcinoma of the lung. Proc Am Assoc Cancer Res ASCO 18:235
Dombernowsky P, Hansen HH, Nissen NI (1976) Treatment of small cell anaplastic carcinoma of the lung with an oral solution of VP-16-213. A Phase II trial. Proc Am Assoc Cancer Res ASCO 17:129
Dombernowsky P, Hansen HH, Hansen M, Sorensen S, Osterlind K, Rorth M, Hansen HS (1980) Treatment of small cell anaplastic bronchogenic carcinoma. Results from 2 randomized trials. In: Hansen HH, Dombernowsky P (eds) II World Conference on Lung Cancer Excerpta Medica, Amsterdam, p 149
Eagan RT, Frytak S, Rubin J (1976) VP16 vs polichemotherapy in small cell lung cancer. Proc Am Assoc Cancer Res ASCO 17:243
Einhorn LH, Fee WH, Farber MD, Livingston RB, Gottlieb J (1976) Improved Chemotherapy for small cell undifferentiated lung cancer. JAMA 235:1225–1229
Feld R, Keen CW, Quirt IC, Curtis JE, Baker MA, Yeoh JL, Deboer G, Brown TC (1981) Combined modality treatment of small cell carcinoma of the lung. Arch Int Med 141:469–473
Fox RM, Tattersall MHN, Woods RL (1981) Radiation therapy as an adjuvant in small cell lung cancer treated by combination chemotherapy: a randomized study. Proc Am Assoc Cancer Res and ASCO 22:502
Fox W, Scadding JG (1973) Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small cell or oat cell carcinoma of the bronchus. Ten years follow up. Lancet 2:63–65
Greco FA, Einhorn LH, Richardson RL, Oldham RK (1978) Small cell lung cancer: Progress and perspectives. Semin Oncol 5:323–335
Greco FA, Richardson RL, Schulman SF, Stroup S, Oldham RK (1978) Treatment of oat cell carcinoma of the lung: complete remissions, acceptable complications, and improved survival. Br Med J 2:10–11
Green RA, Humphrey E, Close H (1969) Alkylating agents in bronchogenic carcinoma. Am J Med 46:516–524
Hansen HH, Rorth M (1979) Lung cancer, epidermoid carcinoma, small cell anaplastic carcinoma, adenocarcinoma, and large cell carcinoma. In: Pinedo HM (ed) Cancer Chemotherapy, Excerpta Medica, Amsterdam, pp 267
Holoye PY, Samuels ML, Lanzotti VJ, Smith T, Barkley HT Jr (1977) Combination chemotherapy and radiation therapy for small cell carcinoma. JAMA 237:1221–1224
Johnson RE, Brerenton HD, Kent HC (1978) “Total” therapy for small cell carcinoma of the lung. Ann Thorac Surg 25:510–515
Kaplan EL, Meier P (1958) Non parametric estimation from incomplete observations. Am Stat Assoc J 53:457–481
Laing AH, Berry RJ, Newman CR, Smith P (1975) Treatment of small cell carcinoma of the bronchus. Lancet 1:129–132
Lee RE, Carr DT, Childs DS Jr (1976) Comparison of split course radiation therapy and continuous radiation therapy: 5 years results. Am J Roentgenol Radium Ther Nucl Med 126:116–122
Livingston RB (1978) Treatment of small cell lung carcinoma: Evaluation and future directions. Semin Oncol 5:299–308
Livingston RB, Moore TN, Heilbrun L, Bottomley R, Lehane D, Rivkin SE, Thrigpen T (1978) Small cell carcinoma of the lung: Combined chemotherapy and radiation. Ann Int Med 88:194–199
Natale RB, Hilaris B, Shank B, Wittes RE (1980) Prolonged remission of Small Cell Lung Carcinoma (SCLC) with intensive chemotherapy induction and high dose radiation therapy without maintenance. In: Hansen HH, Dombernowsky P (eds) II World Converence on Lung Cancer, Abstracts. Excerpta Médica, Amsterdam, p 162
Matthews MJ (1974) Morphology of lung cancer. Semin Oncol 1:175–182
Page RH, Talley RW, Buhagiar J (1977) The enhanced antitumor activity of Cis-diamine dichloroplatinum (II) against murine tumors when combined with other agents. J Clin Hematol Oncol 7:96–104
Sierocki JS, Hilaris BS, Hopfan S, Martini N, Barton D, Golbey RB, Wiltes RE (1979) Cis-diammine dichloroplatinum II and VP16-213: An active induction regimen for small cell carcinoma of the lung. Cancer Treat Rep 63:1593–1597
Zelen M (1973) Keynote address on biostatistics and data retrieval. Cancer Chem Rep (Suppl) 4:31–42
Author information
Authors and Affiliations
Additional information
Send offprint requests to H. Cortés Funes, Section Oncologia Medica, Servicio de Radioterapia y Oncologia
Rights and permissions
About this article
Cite this article
Funes, H.C., Dominguez, P., Torrubia, A.P. et al. Treatment of small cell lung cancer with a combination of VP16-213 and cyclophosphamide with cisplatin or radiotherapy. Cancer Chemother. Pharmacol. 7, 181–186 (1982). https://doi.org/10.1007/BF00254545
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00254545